Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
i-Slim is an Ayurvedic proprietary health supplement developed by Indusviva Health Sciences for the management of obesity and metabolic syndrome. Formulated as a powder for a reconstituted drink, it contains a synergistic blend of natural ingredients including Garcinia indica (Kokum), Coleus forskohlii, Salacia chinensis, and the enzyme Bromelain. The product acts as a fat blocker by inhibiting ATP citrate lyase, which slows the conversion of carbohydrates into fats and halts fat storage. It also activates adenylate cyclase to promote lipolysis and inhibits alpha-glucosidase to modulate carbohydrate metabolism. Additionally, i-Slim is designed to promote satiety and suppress hunger, supporting weight loss through metabolic efficiency and immune function rejuvenation. Clinical studies have demonstrated its efficacy in reducing Body Mass Index (BMI) and skin-fold thickness over a 12-week period.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on i-Slim.